LevoDril 60 mg/10 ml, syrup, 120 ml

LevoDril contains the active substance levodropropizine, which has antitussive and bronchospasm-relieving effects.

LevoDril is indicated for the symptomatic treatment of non-productive (dry) cough in adults and children from 2 years of age.

Much data indicates that this drug is effective in suppressing cough of various origins, such as cough associated with lung cancer, cough associated with upper and lower respiratory tract infections, and whooping cough.

If after 7 days there is no improvement or the patient feels worse, contact your doctor.

• The active substance is levodropropizine. 10 mL of syrup contains 60 mg of levodropropizine.
• Other ingredients are: sucrose, methyl parahydroxybenzoate (E 218), propyl parahydroxybenzoate (E 216), citric acid monohydrate, orange flavour, liquid ORANGE 02 278 NF (contains, among others, ethanol (68-74%), fragrance composition – geraniol, citral), purified water.

Always use this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. If you are not sure, ask your doctor or pharmacist.

Do not use LevoDril for more than 7 days without consulting your doctor.

Use in adults:

• 10 ml of syrup up to 3 times a day.

How to use

LevoDril should be taken orally, 3 times a day at least 6 hours apart. The bottle of syrup comes with a measuring cup that allows you to measure 3, 5 and 10 ml.

Treatment should be continued until the cough disappears or as directed by the doctor. In any case, if the cough does not subside after 7 days of treatment, the drug should be discontinued and a doctor should be consulted. It should be remembered that cough is a symptom of a disease and the disease that causes it should be recognized and then treated.

Use in children from 2 years of age with a body weight of:

• 10-20 kg: 3 ml of syrup 3 times a day,
• 20-30 kg: 5 ml of syrup 3 times a day.

LevoDril should not be used in children under 2 years of age.

• if you are allergic to the active substance or any of the other ingredients of this medicine;
• in people with abundant bronchial secretions and impaired function of the cilia of the bronchial epithelium (Kartagener syndrome, ciliary dyskinesia);
• in pregnant and breastfeeding women.